Product Information
PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) is a brand product labeled by Pfizer Inc., priced at $73.8007 per EA under NDC 00069543420. Its NADAC has been published 53 times since Aug 20, 2025.
FDA first approved this application on May 25, 2023.
Manufacturer
Pfizer Inc.NDC
00069543420
Classification
Brand
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
New Drug (NDA)
FDA Application
NDA217188FDA Approved
5/25/2023
On Market Since
7/9/2025
Price Statistics
The NADAC for PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) has been published 53 times since Aug 20, 2025, and over the history we have for it it has risen 2.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $73.8007 per EA |
|---|---|
| All-time high | $73.8241 (Jun 10, 2026) |
| All-time low | $71.6291 (Dec 17, 2025) |
| 52-week high | $73.8241 |
| 52-week low | $71.6291 |
| Median price | $73.7780 |
| Average price | $73.0507 |
| Largest weekly change | +3.0% (Dec 31, 2025) |
| Weeks tracked | 53 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE)?
The current National Average Drug Acquisition Cost (NADAC) for PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE), manufactured by Pfizer Inc., is $73.8007 per EA (NDC 00069543420), effective Aug 19, 2026.
How has the price of PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) changed over time?
Over the history we have for it, the NADAC for PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) has risen 2.8%. It has been tracked across 53 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE)?
Since Aug 20, 2025, the NADAC for PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) has ranged from a low of $71.6291 (Dec 17, 2025) to a high of $73.8241 (Jun 10, 2026), with a median of $73.7780 per EA.
Are there cheaper alternatives to PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE)?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PAXLOVID 300-100 MG DOSE PACK, is $49.2339 per EA — about 33% below PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE).
Who manufactures PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE)?
PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) (NDC 00069543420) is labeled by Pfizer Inc., and CMS classifies it as a brand product.